GeneDx Holdings Corp.
WGS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,102,667 | $2,638,192 | $2,493,064 | $2,074,728 |
| - Cash | $95,968 | $74,120 | $99,704 | $85,212 |
| + Debt | $113,161 | $114,385 | $114,836 | $116,168 |
| Enterprise Value | $3,119,860 | $2,678,457 | $2,508,196 | $2,105,684 |
| Revenue | $116,743 | $102,692 | $87,115 | $95,640 |
| % Growth | 13.7% | 17.9% | -8.9% | – |
| Gross Profit | $84,527 | $70,902 | $58,476 | $66,205 |
| % Margin | 72.4% | 69% | 67.1% | 69.2% |
| EBITDA | -$352 | $17,571 | $236 | $14,364 |
| % Margin | -0.3% | 17.1% | 0.3% | 15% |
| Net Income | -$7,635 | $10,809 | -$6,529 | $5,438 |
| % Margin | -6.5% | 10.5% | -7.5% | 5.7% |
| EPS Diluted | -0.27 | 0.36 | -0.23 | 0.2 |
| % Growth | -175% | 256.5% | -215% | – |
| Operating Cash Flow | $15,767 | $10,420 | $10,182 | -$3,183 |
| Capital Expenditures | -$6,172 | -$2,369 | -$6,129 | -$3,050 |
| Free Cash Flow | $9,595 | $8,051 | $4,053 | -$6,233 |